Cargando…
miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review
Among deregulated microRNAs (miRs) in human malignancies, miR-221 has been widely investigated for its oncogenic role and as a promising biomarker. Moreover, recent evidence suggests miR-221 as a fine-tuner of chronic liver injury and inflammation-related events. Available information also supports...
Autores principales: | Di Martino, Maria Teresa, Arbitrio, Mariamena, Caracciolo, Daniele, Cordua, Alessia, Cuomo, Onofrio, Grillone, Katia, Riillo, Caterina, Caridà, Giulio, Scionti, Francesca, Labanca, Caterina, Romeo, Caterina, Siciliano, Maria Anna, D'Apolito, Maria, Napoli, Cristina, Montesano, Martina, Farenza, Valentina, Uppolo, Valentina, Tafuni, Michele, Falcone, Federica, D'Aquino, Giuseppe, Calandruccio, Natale Daniele, Luciano, Francesco, Pensabene, Licia, Tagliaferri, Pierosandro, Tassone, Pierfrancesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891816/ https://www.ncbi.nlm.nih.gov/pubmed/35282417 http://dx.doi.org/10.1016/j.omtn.2022.02.005 |
Ejemplares similares
-
miRNAs and lncRNAs as Novel Therapeutic Targets to Improve Cancer Immunotherapy
por: Di Martino, Maria Teresa, et al.
Publicado: (2021) -
Risk Alleles for Multiple Myeloma Susceptibility in ADME Genes
por: Scionti, Francesca, et al.
Publicado: (2022) -
Pharmacogenomics Biomarker Discovery and Validation for Translation in Clinical Practice
por: Arbitrio, Mariamena, et al.
Publicado: (2020) -
miR-22 Modulates Lenalidomide Activity by Counteracting MYC Addiction in Multiple Myeloma
por: Caracciolo, Daniele, et al.
Publicado: (2021) -
Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats
por: Di Martino, Maria Teresa, et al.
Publicado: (2020)